ESMO 2024: Updates on ICARUS-BREAST01 with Dr. Barbara Pistilli

ESMO 2024 - Overall Survival Data from the KEYNOTE-522 Trial with Dr. Peter Schmid

ESMO 2024 - Daily RECAP day 1

ESMO 2024 - Global Speaker Series - Dr. Nancy Lin on ESMO LBA18: Trastuzumab deruxtecan (T-DXd) in patients with HER2+ advanced/mbc & DESTINYBreast-12 primary results

ESMO 2024 - Global Speaker Series - Dr. Alnouri Highlights What to Expect at ESMO 2024: Advances in Breast Cancer